Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS

This study has been completed.

Study NCT00021697 Information provided by Avanir Pharmaceuticals

First Received: August 1, 2001 Last Updated: August 4, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	March 2002
Estimated Primary Completion Date:	No date given